These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5639734)

  • 21. Blair chairs UK health summit to tackle NHS reform.
    Jones J
    BMJ; 2000 Jun; 320(7249):1562. PubMed ID: 10845961
    [No Abstract]   [Full Text] [Related]  

  • 22. Preparation and use of drug master files in the pharmaceutical industry.
    Personeus GR; Ascione P
    J Parenter Sci Technol; 1981; 35(2):63-9. PubMed ID: 7229835
    [No Abstract]   [Full Text] [Related]  

  • 23. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970.
    Tobbell DA
    Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New York State and drug lists: a history of confusion.
    Stetler CJ
    Med Mark Media; 1978 Sep; 13(9):36, 38, 40 passim. PubMed ID: 10316687
    [No Abstract]   [Full Text] [Related]  

  • 26. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 27. The North American Conference of GI Fellows: medicine and the pharmaceutical industry at its best.
    Katz P; Carey W
    Am J Gastroenterol; 1994 Sep; 89(9):1423-4. PubMed ID: 8079916
    [No Abstract]   [Full Text] [Related]  

  • 28. Dissemination of journal reprints by a pharmaceutical company.
    Graham CF
    J Clin Pharmacol; 1996 Feb; 36(2):97. PubMed ID: 8852384
    [No Abstract]   [Full Text] [Related]  

  • 29. No time for doomsday.
    Stetler CJ
    Hosp Formul; 1975 May; 10(5):220-1, 225-6. PubMed ID: 10237838
    [No Abstract]   [Full Text] [Related]  

  • 30. The evolution of new drug legislation.
    Kelsey FO
    BMQ; 1966 Sep; 17(3):72-81. PubMed ID: 5978212
    [No Abstract]   [Full Text] [Related]  

  • 31. Ethics. Clinical trials guidelines at odds with U.S. policy.
    Normile D
    Science; 2008 Oct; 322(5901):516. PubMed ID: 18948510
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 33. The changing face of pharmaceutical advertising. A look at medical journals reveals a new era in advertising.
    Weeks WB; Wallace AE; Kimberly BC
    Mark Health Serv; 2001; 21(3):27-30. PubMed ID: 11525138
    [No Abstract]   [Full Text] [Related]  

  • 34. Doctors, AGA, and industry: steps toward improving the relationship.
    Camilleri M
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):160-6. PubMed ID: 16469675
    [No Abstract]   [Full Text] [Related]  

  • 35. The maturing of the Journal of The American Medical Directors Association.
    Dharmarajan TS
    J Am Med Dir Assoc; 2005; 6(4):287-8. PubMed ID: 16005421
    [No Abstract]   [Full Text] [Related]  

  • 36. Implications of international drug approval systems on confidentiality of business secrets in the U.S. pharmaceutical industry.
    O'Reilly JT
    Food Drug Law J; 1998; 53(1):123-32. PubMed ID: 11795328
    [No Abstract]   [Full Text] [Related]  

  • 37. New drugs: the AMA and the FDA.
    Appel JZ
    Ann Allergy; 1966 Jul; 24(7):333-6. PubMed ID: 5941864
    [No Abstract]   [Full Text] [Related]  

  • 38. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
    Dorfman HL; Reig LP
    Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug names--a semblance of order.
    Feldman EG
    J Pharm Sci; 1966 Jun; 55(6):i. PubMed ID: 5924136
    [No Abstract]   [Full Text] [Related]  

  • 40. Progress under the Kefauver-Harris Drug Amendments.
    Rankin WB
    Pharmakotherapia; 1964; 2(1):215-22. PubMed ID: 5875717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.